|Bid||17.13 x 0|
|Ask||17.26 x 0|
|Day's Range||17.05 - 17.96|
|52 Week Range||12.45 - 19.65|
|Beta (5Y Monthly)||1.85|
|PE Ratio (TTM)||19.52|
|Earnings Date||Feb. 09, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Dec. 20, 2012|
|1y Target Est||23.75|
Has entered into a private agreement with 2945-0228 Québec inc., a company controlled by Mr. Gilles ...
Héroux-Devtek Inc. (TSX: HRX) ("Héroux-Devtek" or the "Corporation") today announced that it has entered into a private agreement with 2945-0228 Québec inc. ("2945"), a company controlled by Mr. Gilles Labbé, Executive Chairman of the Board of Héroux-Devtek, for the repurchase for cancellation of 804,000 common shares of Héroux-Devtek at a price of $18.12 per share, for a total consideration of $14,568,480.
Héroux-Devtek (TSE:HRX) has had a great run on the share market with its stock up by a significant 5.6% over the last...